ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,618.26
      -0.29%
      US Tech 100
      19,224.80
      1.95%
      Dow Jones
      41,503.10
      -0.25%
      Brent Oil
      74.04
      2.29%
      Bitcoin
      62,145.00
      0.77%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. OncoCyte Corporation (OCX)

      7. OncoCyte Corporation (OCX) News

      OCX

      OncoCyte (OCX)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:OCX
      DateTimeSourceHeadlineSymbolCompany
      2:29PMiHub NewswireFeaturedElement79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership
      08/20/20249:00AMGlobeNewswire Inc.PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics TechnologyNASDAQ:OCXOncocyte Corporation
      08/12/20244:10PMGlobeNewswire Inc.Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series StudyNASDAQ:OCXOncocyte Corporation
      08/09/20246:37AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      08/09/20246:25AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OCXOncocyte Corporation
      08/09/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
      08/08/20244:27PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OCXOncocyte Corporation
      08/08/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      08/08/20244:05PMGlobeNewswire Inc.Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 ResultsNASDAQ:OCXOncocyte Corporation
      08/05/20244:05PMGlobeNewswire Inc.Oncocyte Announces August Investor Conferences ParticipationNASDAQ:OCXOncocyte Corporation
      08/01/20244:05PMGlobeNewswire Inc.Oncocyte to Announce Second Quarter 2024 Financial Results on August 8NASDAQ:OCXOncocyte Corporation
      07/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      07/11/20248:00AMGlobeNewswire Inc.MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" EpisodeNASDAQ:OCXOncocyte Corporation
      06/24/202412:41PMGlobeNewswire Inc.Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership MoveNASDAQ:OCXOncocyte Corporation
      06/17/20244:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      06/17/20244:05PMGlobeNewswire Inc.Oncocyte Appoints Andrea James as Chief Financial OfficerNASDAQ:OCXOncocyte Corporation
      06/04/20245:02PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
      06/03/20242:13PMGlobeNewswire Inc.Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft StudyNASDAQ:OCXOncocyte Corporation
      05/31/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      05/30/20244:47PMGlobeNewswire Inc.Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of MedicineNASDAQ:OCXOncocyte Corporation
      05/23/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:OCXOncocyte Corporation
      05/23/202411:26AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OCXOncocyte Corporation
      05/23/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OCXOncocyte Corporation
      05/22/20245:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
      05/22/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OCXOncocyte Corporation
      05/17/20245:11PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:OCXOncocyte Corporation
      05/15/20244:05PMGlobeNewswire Inc.Oncocyte Reports First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
      05/13/20248:00AMGlobeNewswire Inc.Oncocyte to Announce First Quarter 2024 Financial ResultsNASDAQ:OCXOncocyte Corporation
      05/10/20245:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OCXOncocyte Corporation
      05/07/20249:19AMGlobeNewswire Inc.PRISM MarketView Spotlights Oncocyte Corporation as it Works to Disrupt the Precision Diagnostics MarketplaceNASDAQ:OCXOncocyte Corporation
       Showing the most relevant articles for your search:NASDAQ:OCX